Indivior | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AstraZeneca USD 40.87B 66M 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
Glaxosmithkline GBP 13.67B 337M 2024-12
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
Indivior -167000000 46M 2024-09
J&J USD 71.49B 1.33B 2024-12
Kyowa Hakko Kirin JPY 850.81B 15.56B 2024-12
Merck USD 46.31B 1.81B 2024-12
Novartis USD 44.05B 729M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Sanofi 73B 0 2024-09
Supernus Pharmaceuticals USD 1.04B 28.58M 2024-12



Indivior Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.